FDA grants 510(k) clearance to CareTaker Medical’s blood pressure and heart rate monitor

The FDA granted a 510(k) clearance for CareTaker Medical’s wireless continuous non-invasive “beat-by-beat” blood pressure and heart rate monitor.

The monitor uses the company’s finger cuff technology to continuously measure blood pressure and heart rate even when people are sleeping.

CareTaker Medical noted in a news release that many previous “beat-by-beat” monitors have required an invasive arterial catheter or complex equipment and been used mainly in critical care settings. However, this monitor does not require catheters or wires.

“CareTaker is a real game changer, allowing physicians to remotely monitor medical-grade Continuous Blood Pressure and Heart Rate from anywhere, using only a patient friendly-finger cuff” Jay Sanders, MD, an adjunct professor at the Johns Hopkins school of medicine and president emeritus of the American Telemedicine Association, said in a news release. “Until now, most clinicians have had to settle for intermittent ‘point-in-time’ Blood Pressure measurements using bulky arm cuffs, which can produce misleading results due to the influence of many factors such as movement, posture, anxiety, or caffeine. In remote monitoring settings, the ability to gather continuous Blood Pressure and vital sign data from such an integrated easy-to-use device will provide better information and improve patient compliance while reducing cost and workload.”

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Trimed Popup
Trimed Popup